Km. Thrailkill et al., CHARACTERIZATION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 5-DEGRADING PROTEASES PRODUCED THROUGHOUT MURINE OSTEOBLAST DIFFERENTIATION, Endocrinology, 136(8), 1995, pp. 3527-3533
Insulin-like growth factor (IGF)-binding protein-5 (IGFBP-5) is unique
ly regulated throughout MC3T3-E1 osteoblast differentiation: IGFBP-5 i
s first detectable in conditioned medium (CM) of replicating preosteob
lasts (day 5); IGFBP-5 levels peak between culture days 8-12, then dec
line to almost undetectable levels in mature osteoblast cultures (>day
18) despite the persistence of IGFBP-5 messenger RNA. These observati
ons suggest that IGFBP-5 concentrations may be regulated by posttransl
ational mechanisms. To determine whether proteolysis contributes to th
e disappearance of IGFBP-5 in CM of mature osteoblasts, serial samples
of MC3T3-E1 cell CM obtained during a 30-day culture period were anal
yzed for IGFBP-5-degrading protease activity. Using [I-125]recombinant
human IGFBP-5 substrate zymography, we demonstrated that proteases wi
th M(r) of 52-72 and 97 kilodaltons (kDa) were present in CM, and prot
ease activity increased in concentration as cultures matured. The 52-
to 72-kDa proteases were cation dependent and were inhibited by tissue
inhibitor of metalloproteinase 1, a specific inhibitor of matrix meta
lloproteinases (MMPs), identifying them as MMPs. Furthermore, antisera
to human MMP-1 and -2 immunoprecipitated IGFBP-5-degrading proteases
with M(r) of 52 and 69/72 kDa, respectively, suggesting that homologou
s murine MMPs degrade IGFBP-5. Finally, MC3T3-E1 cell CM contained imm
unoreactive MMP-1 and -2, and MMP-2, in particular, increased signific
antly throughout differentiation. In contrast, the 97-kDa protease was
neither inhibited by tissue inhibitor of metalloproteinase 1 nor immu
noprecipitated by antisera to MMPs, suggesting that the 97-kDa proteas
e is not a MMP. Together, these data suggest that MMPs along with an u
nidentified 97-kDa protease degrade IGFBP-5 in MC3T3-E1 cell cultures.
Because truncated forms of IGFBP-5 have been shown to enhance the act
ion of IGF in bone cells, IGFBP-5 proteases may be instrumental in IGF
-mediated bone morphogenesis.